Gritstone Bio to Participate in Upcoming Investor and Scientific Conferences
Gritstone Bio to Participate in Upcoming Investor and Scientific Conferences
EMERYVILLE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today announced that management will be participating in the following investor and scientific conferences:
加州埃默裏維爾，2024年6月4日（環球社交傳媒）——生物技術臨床階段的Gritstone bio公司（納斯達克：GRTS）正在開發全球最強效的疫苗，並宣佈管理層將參加以下投資者和科學會議：
Goldman Sachs 45th Annual Global Healthcare Conference (Fireside Chat*)
Date and Time: Tuesday, June 11, 2024 at 1:20pm ET
Location: Miami, FL
高盛第45屆全球保健大會（火爐聊天*）
日期和時間：2024年6月11日（美國東部時間）下午1:20
地點：佛羅里達州邁阿密
JonesHealthcare Seaside Summit 2024 (1x1s)
Dates: Monday, July 15 - Tuesday, July 16
Location: Encinitas, CA
JonesHealthcare Seaside Summit 2024（1x1s）
日期：7月15日星期一-7月16日星期二
地點：加利福尼亞州恩西尼塔斯
4th Annual mRNA-Based Therapeutics Summit (Panel)
Panel Title: Unpacking 2024's Successes & Anticipating the Next Challenges to Advance the Future of mRNA-Based Therapeutics & Vaccines
Date and Time: Tuesday, July 30, 2024 at 8:30am ET
Location: Boston, MA
4th年度基於mRNA的治療峯會（面板）
面板標題：揭示2024年的成功和預測推進基於mRNA的治療和疫苗的未來的下一個挑戰。
日期和時間：2024年7月30日上午8:30（美國東部時間）
地點：馬薩諸塞州波士頓
Select events (marked by *) will be webcasted live and webcast details will be available on the 'Events' page of Gritstone bio's website: https://ir.gritstonebio.com/investors/events. Archived replays will be accessible for 30 days following each event.
標有*的選擇活動將現場網絡直播，網絡直播細節將在gritstone bio網站的“活動”頁面上公佈。https://ir.gritstonebio.com/investors/events存檔的重播將在每個事件後的30天內可訪問。
About Gritstone bio
Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world's most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio of product candidates to treat and prevent viral diseases and solid tumors in pursuit of improving patient outcomes and eliminating disease. www.gritstonebio.com
關於gritstone bio
Gritstone bio公司（納斯達克：GRTS）是一家臨床階段的生物技術公司，旨在開發全球最強效的疫苗。我們利用創新的載體和負載來訓練多個免疫系統去攻擊重要的疾病目標。獨立和與我們的合作伙伴一起，我們正在推進一系列治療和預防病毒性疾病和實體腫瘤的產品候選方案，以追求改善患者預後和消除疾病。www.gritstonebio.com
Gritstone Contacts
Investors:
George E. MacDougall
Gritstone bio, Inc.
ir@gritstone.com
gritstone聯繫人
投資者：
George E. MacDougall
gritstone bio, Inc.
ir@gritstone.com
Media:
Dan Budwick
1AB
(973) 271-6085
dan@1abmedia.com
媒體：
Dan Budwick
1AB
(973) 271-6085
dan@1abmedia.com
譯文內容由第三人軟體翻譯。